Syneron Medical Ltd. (
Q4 2011 Earnings Call
February 9, 2012 8:30 am ET
Dr. Shimon Eckhouse – Chairman
Louis Scafuri – Chief Executive Officer
Asaf Alperovitz – Chief Financial Officer
Anthony Vendetti – Maxim Group
Dalton Chandler – Needham & Co.
Jeremy Feffer – Cantor Fitzgerald
Richard Newitter – Leerink Swann
Good day ladies and gentlemen and welcome to the Syneron Medical Fourth Quarter 2011 Results conference call. At this time, all participants are in a listen-only mode. Later we’ll conduct a question and answer session and instructions will follow at that time. If anyone should require assistance, please press star then zero on your touchtone telephone. As a reminder, this conference is being recorded.
I would now like to turn the call over to your host, Zach Kubow. Please go ahead, sir.
– The Ruth Group
Thank you, Operator. I’d like to welcome everyone to Syneron Medical’s Fourth Quarter 2011 conference call, which will also cover the Company’s acquisition of Ultrashape that was announced yesterday. Statements on this call may be forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 relating to the Company’s future events or future performance, including statements with respect to Syneron’s expectations regarding but not limited to the financial forecast for 2012, the launch of new products, the acquisition and integration of Ultrashape, and the maintenance of a leadership position in core and non-core markets.